title: Stent thrombosis redux--the FDA perspective.
authors.affiliation: Interventional Cardiology Devices Branch, of the Office of Device Evaluation, Center for Devices and Radiological Health, FDA, Rockville, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Farb
authors.forename: Ashley B
authors.initials: AB
authors.lastname: Boam
mesh_terms: D026683:Advisory Committees; D015906:Angioplasty, Balloon, Coronary; D003327:Coronary Disease / Q000628:therapy*; D003328:Coronary Thrombosis / Q000209:etiology*; D018795:Device Approval; D016503:Drug Delivery Systems; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012306:Risk; D015607:Stents / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration